Α' Department of Propaedeutic Surgery
FUNDED RESEARCH PROJECTS
- MUT SCREENING
Objective:
Histopathological verification of MUT (multimodal ultrasound tomography) imaging results for multiple malignant lesions detected by MUT imaging
Project Management:
Prof G. Zografos, Prof V. Marmarellis
Technical Support: Dr. M Sofras, Dr E Groumbas
- TAXINOMISIS:A multidisciplinary approach for the stratification of patients with carotid artery disease
Objective:
Collaboration of several research fields in order to establish better and more personalized criteria for the stratification of patients with carotid artery disease. Thus, TAXINOMISIS aims to reduce unnecessary operations, refine medical treatment and open up new avenues for therapeutic intervention.
Funded under:
"HORIZON 2020" research and innovation programme
EUROPEAN UNION Grant agreement ID: 755320
Project Management:
Fragiska Sigala (scientific supervisor)
Konstantinos Filis
Useful links:
https://cordis.europa.eu/project/rcn/212692/results/en
https://taxinomisis-project.eu/wp-content/uploads/2018/07/TAXINOMISIS_Brochure_v3.pdf
https://taxinomisis-project.eu/wp-content/uploads/2019/10/TAXINOMISIS_Brochure_2019.pdf
- VISION:Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSis of gastrOintestinal caNcers
Objective:
VISION constitutes a scientific collaboration between five internationally recognized institutions, with Biomedicinske centrum Slovenskej akademie vied (Slovakia) being the coordinator. Its main purpose is to strengthen the scientific excellence and find innovative solutions in the early detection of cancer, particularly of the gastrointestinal tract.
Funded under:
"HORIZON 2020" research and innovation programme
EUROPEAN UNION Grant agreement ID: 857381
Project Management:
Μanousos M. Konstadoulakis (scientific supervisor)
Agapi Kataki (communication management)
Useful links:
https://cordis.europa.eu/project/rcn/224231/factsheet/en
- NExT: Establishing an algorithm for the early diagnosis and follow – up of patients with pancreatic neuroendocrine tumors.
Objective:
This multidisciplinary collaboration involves six institutions, with Fraunhofer Institute for Biomedical Engineering (IBMT) in Germany being the coordinator. Pancreatic neuroendocrine tumors (PNET)are relative rare, heterogeneous tumors which lack risk stratification systems. Resection comprises the primary therapy, with most patients not being suitable candidates. This project aims to deliver a nanotechnology-based microfluidic (next generation) device that will aid in the early detection and follow-up of patients with PNET tumors.
Funded under:
4th Joint Transnational Call (JTC 2017) ERA-NET
EUROPEAN UNION Grant agreement ID: 0711
Project Management:
Manousos M. Konstadoulakis (Scientific Supervisor)
Useful links:
https://www.next-project.eu/
https://www.transcanfp7.eu/index.php/abstract/next.html
https://www.transcanfp7.eu/images/documents/NEWSLETTERS/TRANSCAN-2_newsletter_May_2019.pdf